Articles by: Kristin Rhodes

Wal-Mart Stores, Inc. (NYSE:WMT) Collaborates With International Business Machines Corp. (NYSE:IBM) And Tsinghua University To Use Blockchain For Safety Of Chinese Pork

Wal-Mart Stores, Inc. (NYSE:WMT) Collaborates With International Business Machines Corp. (NYSE:IBM) And Tsinghua University To Use Blockchain For Safety Of Chinese Pork

Wal-Mart Stores, Inc. (NYSE:WMT), with International Business Machines Corp. (NYSE:IBM) and Tsinghua University works on the initiation of using blockchain as a tool to trace supply chain of pork from China. Announced today with the opening of Walmart Food Safety Collaboration Center in Beijing, the collaboration is expected to yield safer pork in China. By using blockchain, information about the[Read More…]

by October 19, 2016
Samumed’s Experimental Drug Initial Results Show Effective Bald Treatment

Samumed’s Experimental Drug Initial Results Show Effective Bald Treatment

A presentation to the American Academy of Dermatology in Washington, D.C. has shown that an experimental drug from Samumed, an unknown San-Diego-based biotechnology firm, is efficient in growing hair among bald men. The preliminary data, delivered by Yusuf Yazici, Samumed Chief Medical Officer, have demonstrated ‘promising’ results. However, there are many concerns whether the drug will hold up in larger[Read More…]

by October 18, 2016
Biotech Stocks Update: Celgene Corporation (NASDAQ:CELG), Pfizer, Inc. (NYSE:PFE), WebMD Health Corporation (NASDAQ:WBMD)

Biotech Stocks Update: Celgene Corporation (NASDAQ:CELG), Pfizer, Inc. (NYSE:PFE), WebMD Health Corporation (NASDAQ:WBMD)

Celgene Corporation (NASDAQ:CELG) Celgene predicts a whopping $21 billion sales by 2020, marking over 100% increase from its sales today. Currently, the company has a total amount of $7.50 billion cash on hand. Celgene holds a ‘cheap’ forward price to earnings (P/E) ratio of 13.85. Investors remain optimistic about the healthcare company’s upbeat projections. Moreover, a great cash-on-hand also indicates[Read More…]

by September 16, 2016
Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) Reports Q4, FY2015 Results

Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) Reports Q4, FY2015 Results

Fresenius Medical Care AG & Co. released its earnings report for the fourth quarter and full-year. FY2015 witnessed a decline in net income to $1.03 billion from the $1.05 billion of 2014. In line with this, the company posted earnings per share (EPS) of $3.38, down from the previous year’s EPS of $3.46. Furthermore, Fresenius Medical Care’s full-year operating income[Read More…]

by August 24, 2016